Effectiveness of evolocumab for patients with familial hypercholesteraemia (FH) in European clinical practice - Sorbonne Université Access content directly
Conference Papers Year : 2019

Effectiveness of evolocumab for patients with familial hypercholesteraemia (FH) in European clinical practice

No file

Dates and versions

hal-03970100 , version 1 (02-02-2023)

Identifiers

  • HAL Id : hal-03970100 , version 1

Cite

K Ray K, M Schoonen, L Annemans, A van Hout B, M Sibartie, et al.. Effectiveness of evolocumab for patients with familial hypercholesteraemia (FH) in European clinical practice. Congress of the European-Society-of-Cardiology (ESC) / World Congress of Cardiology, Aug 2019, Paris, France. ⟨hal-03970100⟩
2 View
0 Download

Share

Gmail Mastodon Facebook X LinkedIn More